The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

Journal of NeuroVirology

Volumn 8, Issue SUPPL. 2, 2002, Pages 115-121

  Sacktor, Ned ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognition disorders; Dementia; Epidemiology; HIV; Infection; Polyneuropathies

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; STAVUDINE; ZALCITABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN LYMPHOMA; CENTRAL NERVOUS SYSTEM INFECTION; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFICACY; FUNGAL MENINGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LYMPHOCYTOPENIA; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SENSORY NEUROPATHY; TOXOPLASMOSIS; VIRUS LOAD;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036948147     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280290101094     Document Type: Review

References (18)

1. Ammassari A, Cingolani A, et al (2000). AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55: 1194-1200.
2. Brodt HR, Kamps BS, et al (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11: 1731-1738.
3. Centers for Disease Control and Prevention (2001). HIV/AIDS surveillance report. US Department of Health and Human Services Public Health Service: Atlanta, Georgia.
4. Childs EA, Lyles RH, et al (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607-613.
5. Clifford DB, Yiannoutsos C, et al (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623-625.
6. Dore GJ, Correll PK, et al (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249-1253.
7. Grant AD, Djomand G, et al (1997). Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'lvoire. AIDS 11: 1357-1364.
8. Joint United Nations Program on HIV/AIDS (2001). AIDS epidemic update-December 2001. UNAIDS and the World Health Organization: Geneva, Switzerland.
9. Maschke M, Kastrup O, et al (2000). Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 69: 376-380.
10. McArthur JC, Hoover DR, et al (1993). Dementia in AIDS patients: Incidence and risk factors. Neurology 43: 2245-2252.
11. Mocroft A, Katlama C, et al (2000). AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 356: 291-296.
12. Moore RD, Chaisson RE (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 13: 1933-1942.
13. Perriens JH, Mussa M, et al (1992). Neurological complications of HIV-1 seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr 5: 333-340.
14. Sacktor N, Bacellar H, et al (1996). Psychomotor slowing in HIV infection: a predictor of dementia, AIDS, and death. J NeuroVirol 2: 404-410.
15. Sacktor N, McArthur J (1997). Prospects for therapy of HIV-associated neurologic disease. J NeuroVirol 3: 89-101.
16. Sacktor NC, Lyles RH, et al (2001). HIV-associated neurological disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.
17. Satishchandra P, Nalini A, et al (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian Med Res 111: 14-23.
18. Stern Y, McDermott M, et al (2001). Factors associated with incident HIV dementia. Arch Neurol 58: 473-479.